Sweden: Market for Medicaments Containing Corticosteroid Hormones 2024

Market Size for Medicaments Containing Corticosteroid Hormones in Sweden

The Swedish medicaments containing corticosteroid hormones market skyrocketed to $X in 2021, picking up by 282% against the previous year. Over the period under review, consumption recorded a significant expansion. As a result, consumption reached the peak level and is likely to continue growth in the immediate term.

Production of Medicaments Containing Corticosteroid Hormones in Sweden

In value terms, medicaments containing corticosteroid hormones production expanded modestly to $X in 2021 estimated in export price. The total output value increased at an average annual rate of +5.6% over the period from 2012 to 2021; however, the trend pattern indicated some noticeable fluctuations being recorded in certain years. The pace of growth was the most pronounced in 2013 with an increase of 63% against the previous year. Medicaments containing corticosteroid hormones production peaked at $X in 2015; however, from 2016 to 2021, production remained at a lower figure.

Exports of Medicaments Containing Corticosteroid Hormones

Exports from Sweden

In 2021, shipments abroad of medicaments containing corticosteroid hormones decreased by -19.1% to X tons, falling for the second year in a row after two years of growth. The total export volume increased at an average annual rate of +3.1% over the period from 2012 to 2021; however, the trend pattern indicated some noticeable fluctuations being recorded in certain years. The most prominent rate of growth was recorded in 2013 with an increase of 38% against the previous year. Over the period under review, the exports attained the peak figure at X tons in 2019; however, from 2020 to 2021, the exports remained at a lower figure.

In value terms, medicaments containing corticosteroid hormones exports reduced notably to $X in 2021. Overall, exports saw a mild decrease. The pace of growth was the most pronounced in 2013 with an increase of 48%. Over the period under review, the exports reached the peak figure at $X in 2014; however, from 2015 to 2021, the exports stood at a somewhat lower figure.

Exports by Country

China (X tons) was the main destination for medicaments containing corticosteroid hormones exports from Sweden, accounting for a 22% share of total exports. Moreover, medicaments containing corticosteroid hormones exports to China exceeded the volume sent to the second major destination, Russia (X tons), twofold. Hungary (X tons) ranked third in terms of total exports with a 5.7% share.

From 2012 to 2021, the average annual rate of growth in terms of volume to China totaled +30.5%. Exports to the other major destinations recorded the following average annual rates of exports growth: Russia (+35.0% per year) and Hungary (+14.3% per year).

In value terms, the largest markets for medicaments containing corticosteroid hormones exported from Sweden were China ($X), Canada ($X) and France ($X), together comprising 33% of total exports. These countries were followed by the UK, Germany, Russia, Japan, the United Arab Emirates, Spain, Egypt, Australia, Hungary and the Netherlands, which together accounted for a further 39%.

The Netherlands, with a CAGR of +56.9%, recorded the highest growth rate of the value of exports, in terms of the main countries of destination over the period under review, while shipments for the other leaders experienced more modest paces of growth.

Export Prices by Country

In 2021, the average medicaments containing corticosteroid hormones export price amounted to $X per ton, increasing by 2.6% against the previous year. Over the period under review, the export price, however, saw a noticeable curtailment. The pace of growth was the most pronounced in 2013 when the average export price increased by 7.6% against the previous year. As a result, the export price attained the peak level of $X per ton. From 2014 to 2021, the average export prices failed to regain momentum.

Prices varied noticeably country of destination: the country with the highest price was Canada ($X per ton), while the average price for exports to Hungary ($X per ton) was amongst the lowest.

From 2012 to 2021, the most notable rate of growth in terms of prices was recorded for supplies to Canada (+6.7%), while the prices for the other major destinations experienced more modest paces of growth.

Imports of Medicaments Containing Corticosteroid Hormones

Imports into Sweden

For the third year in a row, Sweden recorded growth in overseas purchases of medicaments containing corticosteroid hormones, which increased by 3.7% to X tons in 2021. In general, imports, however, showed a abrupt curtailment. The most prominent rate of growth was recorded in 2020 with an increase of 8.2%. Imports peaked at X tons in 2012; however, from 2013 to 2021, imports remained at a lower figure.

In value terms, medicaments containing corticosteroid hormones imports skyrocketed to $X in 2021. Overall, total imports indicated a mild increase from 2012 to 2021: its value increased at an average annual rate of +1.1% over the last nine years. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2021 figures, imports increased by +51.7% against 2016 indices. The pace of growth was the most pronounced in 2013 with an increase of 30%. As a result, imports attained the peak of $X. From 2014 to 2021, the growth of imports remained at a somewhat lower figure.

Imports by Country

In 2021, Denmark (X tons) constituted the largest medicaments containing corticosteroid hormones supplier to Sweden, with a 41% share of total imports. Moreover, medicaments containing corticosteroid hormones imports from Denmark exceeded the figures recorded by the second-largest supplier, Germany (X tons), threefold. Italy (X tons) ranked third in terms of total imports with an 11% share.

From 2012 to 2021, the average annual growth rate of volume from Denmark stood at -3.3%. The remaining supplying countries recorded the following average annual rates of imports growth: Germany (-11.0% per year) and Italy (+22.3% per year).

In value terms, Denmark ($X) constituted the largest supplier of medicaments containing corticosteroid hormones to Sweden, comprising 44% of total imports. The second position in the ranking was taken by Belgium ($X), with a 21% share of total imports. It was followed by France, with an 11% share.

From 2012 to 2021, the average annual growth rate of value from Denmark was relatively modest. The remaining supplying countries recorded the following average annual rates of imports growth: Belgium (+12.0% per year) and France (+6.5% per year).

Import Prices by Country

In 2021, the average medicaments containing corticosteroid hormones import price amounted to $X per ton, jumping by 22% against the previous year. Over the period under review, import price indicated strong growth from 2012 to 2021: its price increased at an average annual rate of +9.3% over the last nine years. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. The most prominent rate of growth was recorded in 2013 an increase of 34%. Over the period under review, average import prices reached the peak figure in 2021 and is expected to retain growth in the near future.

There were significant differences in the average prices amongst the major supplying countries. In 2021, the country with the highest price was Belgium ($X per ton), while the price for Norway ($X per ton) was amongst the lowest.

From 2012 to 2021, the most notable rate of growth in terms of prices was attained by Belgium (+15.0%), while the prices for the other major suppliers experienced more modest paces of growth.

Source: IndexBox Platform

Frequently Asked Questions (FAQ) :